InviMed
InviMed is a Polish fertility clinic network founded in 2001, operating six locations and providing IVF, insemination, fertility preservation, genetic testing, and gynecological care to individuals and couples experiencing infertility.
- Company typePrivate
- Founded2001
- HeadquartersWarszawa, Poland
- Headcount—
- GTM typeB2C
- OfferingServices
What InviMed does
InviMed is a Polish fertility clinic network founded in 2001 and operated by the legal entity Medi Partner Sp. z o.o. as part of the broader Medicover Group. The company runs six clinics across major Polish cities — Warsaw (Mokotów and Praga districts), Wrocław, Poznań, Gdynia, and Katowice — providing infertility diagnostics, in vitro fertilization (IVF), intrauterine insemination, oocyte and sperm donation programs, fertility preservation including oncofertility, and gynecological and urogynecological physiotherapy. It claims over 13,000 children born through its treatments and a 65% pregnancy success rate, positioning itself as the first IVF clinic established in Poland.
The core technology stack is the embryology laboratory, where InviMed deploys advanced sperm-selection and embryo-handling techniques: ICSI, IMSI at 6,000x magnification, PICSI® hyaluronan-binding selection, two-stage hbIMSI, Oosight™ polarized-light oocyte evaluation, ZyMōt microfluidic chips, EmbryoGlue® transfer medium, vitrification, and preimplantation genetic testing (PGT-A and PGT-M). The diagnostic menu extends to semen analysis, AMH ovarian reserve testing, the eBIOM endometrial microbiome test, Test Adventia, Test Rodinia, NutriGen nutrigenetic testing, and VERACITY non-invasive prenatal testing. Adjacent services include psychological support, acupuncture, urogynecological physiotherapy, and aesthetic gynecology (MonaLisa Touch laser) at the Gdynia clinic. Patient acquisition runs through a 500 900 888 hotline, online booking forms, walk-in registration, organic search, a multilingual blog, social media, the MediClub loyalty program, the Medicover insurance network, and Poland's National Health Fund (NFZ) IVF reimbursement program (up to three subsidized cycles for eligible patients). Private IVF cycles are priced at 8,000–15,000 PLN (~$2,000–$3,800), and revenue is generated on a fee-for-service basis across both private and publicly funded channels.
InviMed firmographics
Firmographics- Name
- InviMed
- Legal name
- Medi Partner Sp. z o.o.
- Website
- https://invimed.pl
- Company type
- Private
- Founded year
- 2001
- Operating status
- Operating
- Short description
- InviMed is a Polish fertility clinic network founded in 2001, operating six locations and providing IVF, insemination, fertility preservation, genetic testing, and gynecological care to individuals and couples experiencing infertility.
- Ownership category
- akta.pro rank
InviMed industry classification
Industry- Product category
- Fertility Clinics and Reproductive Medicine
- NAICS
- Offices of Physicians (6211), Other Ambulatory Health Care Services (6219)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)
- akta.pro secondary industries
- Reproductive Endocrinology & Infertility (IVF/Fertility) (HLAKAJAC), Genetic Counseling & Prenatal Testing Telehealth (carrier screening, NIPT counseling) (HLALAHAK)
Keywords
Where InviMed is headquartered
LocationHeadquarters
- HQ city
- Warszawa
- HQ country
- Poland
- HQ region
- Europe
Offices6 records
Markets served
InviMed business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Private Medical Services: Direct patient payments for fertility treatments including IVF, insemination, diagnostics, genetic testing, and consultations. Services available at all 6 clinic locations on a fee-for-service basis.
- Government IVF Reimbursement (NFZ): Participation in the national public IVF subsidy program. Patients meeting eligibility criteria can receive reimbursement for up to 3 IVF attempts. Also includes regional subsidies such as for residents of Mazovia voivodeship.
- MediClub Loyalty Program: Free discount program offering reduced prices on consultations and treatments for enrolled members.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | IVF Treatment Cycle (Private) |
| Subscription | Multi-year contract | NFZ/Government Funded IVF |
Go-to-market motion1 record
Distribution channels5 records
Marketing channels6 records
InviMed product offering
Product offeringCore offering
InviMed operates a network of fertility clinics in Poland delivering assisted reproduction services, including in vitro fertilization (IVF), intrauterine insemination (IUI), fertility diagnostics, embryology and andrology laboratory work, preimplantation and prenatal genetic testing, and gamete/embryo cryopreservation. The clinics serve individuals and couples seeking to conceive, including patients enrolled through the state-funded NFZ program and self-paying private patients.
Product overview
Invimed is a network of infertility treatment clinics offering a comprehensive portfolio of assisted reproduction services. The core offering centers on In vitro (IVF) fertilization, supplemented by intrauterine insemination and oocyte adoption programs. The company provides extensive diagnostic services including genetic testing (Test Adventia, eBIOM, Test Rodinia, NutriGen), prenatal testing (VERACITY), AMH testing, semen analysis, and endometriosis diagnostics. Advanced laboratory techniques include ICSI, IMSI, PICSI®, hbIMSI, the Oosight™ oocyte evaluation system, EmbryoGlue®, vitrification, and embryo adoption with a guarantee of three high-quality embryos. Supporting services include fertility preservation (egg freezing, oncofertility), urogynecological physiotherapy, psychological support, and acupuncture. The company operates six clinics across Poland (Warsaw Mokotów, Warsaw Praga, Wrocław, Poznań, Gdynia, Katowice) and offers both private services and government-funded IVF reimbursement programs.
Differentiator
Problem solved
Functional benefit
Brands
- MediClub: Free discount program for Invimed patients offering various benefits and savings on services.
- Oocyte Adoption Programme with Guarantee
Products and services
- In Vitro Fertilization (IVF / ICSI)
Quantifiable outcome
- 65% pregnancy rate
- +2 more outcomes
Companies that use InviMed
Customer profileSegments4 records
Ideal customer profiles2 records
InviMed technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
InviMed partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Medi Partner Sp. z o.o.coreMedi Partner Sp. z o.o. is the parent company operating the InviMed clinics. The company is part of the Medicover Group (Grupa Medicover), a larger healthcare services organization. Medi Partner handles data processing, operations, and administration for InviMed fertility clinics.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
InviMed competitors and assessment
Company assessmentDirect peers
- Gyncentrum: Polish fertility and reproductive medicine clinic based in Katowice and other cities, offering IVF, ICSI, egg donation, and genetic diagnostics — a direct competitor in the same Polish patient market with similar service breadth.
- Vitrolive: Polish IVF clinic chain with multiple locations, competing head-to-head with InviMed on IVF/ICSI, egg donation programs, and PGT, often referenced in the same competitive set by Polish patients.
- Klinika Bocian: Polish fertility clinic chain operating multiple sites across major Polish cities, directly competing with InviMed on IVF, IUI, and genetic testing with overlapping payor mix including private and NFZ-funded cycles.
- Centrum Medyczne Macierzyństwo: Established Polish fertility clinic offering IVF, IUI, and reproductive diagnostics across several cities, competing for the same NFZ-subsidized and private-pay patients as InviMed.
Broad incumbents
- IVI-RMA Global: One of the world's largest assisted reproduction groups (IVI + RMA), operating across Europe, the Americas, and the Middle East. Comparable as a premium global fertility brand investing in advanced ART lab technology similar to InviMed's IMSI/PICSI stack.
- TFP Fertility: Large European fertility clinic network (UK, Poland, Germany, Netherlands, Austria, Denmark). Comparable as a multi-country IVF operator with overlapping technologies (ICSI, PGT) and similar mix of private and public payors.
- Medicover: Parent healthcare group operating InviMed, Medicover hospitals, and primary care across Poland and CEE. Comparable as the broader healthcare ecosystem InviMed sits within and as a benchmark for clinic-level economics and corporate strategy.
- Virtus Health: Australian-listed global fertility provider with operations in Australia, Ireland, the UK, and Denmark. Comparable as a multi-clinic fertility network with similar service portfolio (IVF, ICSI, PGT, donor programs) at scale.
Regional players
- Genea Biomedx: Australian-headquartered global fertility group (clinics plus medical devices like Gavi, Geri). Comparable as an integrated ART lab technology and clinic operator and as a benchmark for advanced embryo culture and vitrification capabilities used by InviMed.
Others
- Progyny: US fertility benefits and care management company partnering with employer-sponsored plans. Comparable as a model for how employer/insurance-funded fertility care (similar to Medicover's role for InviMed) can be packaged and scaled commercially.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
InviMed social profiles
Digital presenceInviMed financial estimates
Financial estimateRevenue estimate
Valuation estimate
InviMed leadership team
Management profileNumber of profiles
Profiles2 records
InviMed funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
InviMed M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about InviMed
What does InviMed do?
InviMed operates a network of fertility clinics in Poland delivering assisted reproduction services, including in vitro fertilization (IVF), intrauterine insemination (IUI), fertility diagnostics, embryology and andrology laboratory work, preimplantation and prenatal genetic testing, and gamete/embryo cryopreservation. The clinics serve individuals and couples seeking to conceive, including patients enrolled through the state-funded NFZ program and self-paying private patients.
Is InviMed a public or private company?
InviMed is a private company. It is classified as corporate owned and is currently operating.
When was InviMed founded?
InviMed was founded in 2001.
Where is InviMed based?
InviMed is headquartered in Warszawa, Poland, in the Europe region.
How does InviMed make money?
Three revenue lines are on record. Private Medical Services are the primary driver. The others are government IVF Reimbursement (NFZ) and mediClub Loyalty Program.
Who are InviMed's main competitors?
Direct peers on record are Gyncentrum, Vitrolive, Klinika Bocian and Centrum Medyczne Macierzyństwo. Broad incumbents are IVI-RMA Global, TFP Fertility, Medicover and Virtus Health. Genea Biomedx is listed as a regional player. Progyny is listed as an others.
Does InviMed have an API?
No public API is recorded for InviMed.
What industry is InviMed in?
InviMed's product category is Fertility Clinics and Reproductive Medicine. Its primary akta.pro industry code is HLAFAJAD, Fertility, Reproductive Endocrinology & IVF Centers, with a secondary code of HLAKAJAC, Reproductive Endocrinology & Infertility (IVF/Fertility). Its NAICS code is 6211 and its SIC code is 8011.